The prices of sixty subsidized medications will be cut from May 1, the National Health Insurance Fund (OEP) told MTI.
The average extent of the price reduction is 14%, but several medications will become 30-40% cheaper. The products affected by the price cut include those for the treatment of high blood-pressure, high cholesterol and depression, OEP said in the statement.
OEP said the price reduction is due to the fact that it launched price competition in April among combination drugs containing several active ingredients. Almost one-third of the products affected by the price change are combination drugs, OEP said.
Including these changes, OEP announced price changes three times over the past one month, and each resulted in an average drop in the price to the consumer, the announcement said.